[1]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].J Clin Hepatol, 2004, 12 (4) :197-203. (in Chinese) 中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].临床肝胆病杂志, 2004, 12 (4) :197-203.
|
[2]LOU GH, LIU YN, YIN CB, et al.Preliminary study of HCV mouse model induced by infectious HCV 2a plasmid[J].J Clin Hepatol, 2011, 27 (1) :72-75. (in Chinese) 楼国华, 刘艳宁, 尹春本, 等.应用感染性丙型肝炎病毒2a质粒制备小鼠丙型肝炎模型的初步研究[J].临床肝胆病杂志, 2011, 27 (1) :72-75.
|
[3]YANG M, RAO HY.Key points of the AASLD’s guidelines on hepatitis C diagnosis and treatment[J].J Clin Hepatol, 2013, 29 (2) :9-14. (in Chinese) 杨明, 饶慧瑛.美国肝病学会丙型肝炎诊治指南要点[J].临床肝胆病杂志, 2013, 29 (2) :9-14.
|
[4]COLIN C, LANOIR D, TOUZET S, et al.Senstivity and specificity of third-generation hepatitis C virus antibody detection assay:an analysis of the literature[J].J Viral Hepat, 2001, 8 (1) :87-95.
|
[5]LI JM.Clinical enzyme immunoassay technology[M].Beijing:People's Military Medical Press, 2005:10. (in Chinese) 李金明.临床酶免疫测定技术[M].北京:人民军医出版社, 2005:10.
|
[6]KATO N.Molecular virology of hepatitis C virus[J].Acta Med Okayama, 2001, 55 (3) :133-159.
|
[7]XIE L, WU XD.Research advances in detection method for hepatitis C virus and its clinical significance[J].World Chin J Dig, 2005, 13 (7) :884-886. (in Chinese) 谢立, 吴晓东.丙型肝炎病毒检测方法的研究进展及其临床意义[J].世界华人消化杂志, 2005, 13 (7) :884-886.
|
[1] | Yishan LIU, Lanting ZHANG, Yunyu ZHAO, Fanpu JI, Qinglei ZENG. Management of hepatitis C in children and pregnant women[J]. Journal of Clinical Hepatology, 2024, 40(4): 654-658. doi: 10.12449/JCH240402 |
[2] | Zhang HaiPing, Yan HuiPing. Research advances in autoantibodies in autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 749-753. doi: 10.3969/j.issn.1001-5256.2020.04.007 |
[3] | Xue Mei, Shen Yi, Shen MengYi, Fan XiaoLi, Men RuoTing, Yang Li. Autoimmune hepatitis-related autoantibodies and their clinical significance[J]. Journal of Clinical Hepatology, 2019, 35(6): 1392-1396. doi: 10.3969/j.issn.1001-5256.2019.06.048 |
[4] | Han Ying, Chen Jie, Dan Jing, Liu YanMin, Zhang XiaoDan, Ren MeiXin, Du XiaoFei, Bian XinQu, Liu Dan, Huang YunLi, Huang ChunYang, Liao HuiYu. Value of fumarate hydratase antibody in differential diagnosis of autoimmune hepatitis and drug-induced liver injury[J]. Journal of Clinical Hepatology, 2019, 35(6): 1326-1329. doi: 10.3969/j.issn.1001-5256.2019.06.029 |
[5] | Fan ZuoPeng, Liang Shan, Nie Wei, Chou LiXia, Chen Jie, Zhang Jing, Jin RongHua, Hu ZhongJie. Application of drug lymphocyte stimulation test using cell counting kit-8 assay in diagnosis of acute drug-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(8): 1562-1565. doi: 10.3969/j.issn.1001-5256.2016.08.026 |
[6] | Lu: Jing, Xing Feng, Yuan JiLi, Liu ChengHai. A case of autoimmune hepatitis with positive hepatitis C antibody[J]. Journal of Clinical Hepatology, 2016, 32(5): 957-959. doi: 10.3969/j.issn.1001-5256.2016.05.035 |
[7] | Guo FeiBo, Wu JunZhu. Efficacy comparative of different laboratory test reagents for hepatitis C virus antibody[J]. Journal of Clinical Hepatology, 2016, 32(9): 1725-1728. doi: 10.3969/j.issn.1001-5256.2016.09.018 |
[8] | Zhen ZhiJun. A study on optimizing reporting process for hepatitis C virus antibody test for blood donors in blood center′ laboratory [J]. Journal of Clinical Hepatology, 2015, 31(8): 1275-1277. doi: 10.3969/j.issn.1001-5256.2015.08.022 |
[9] | Sun Mei, Tan GuoLei, Wang JianFang, Wu XuPing. Evaluation of two generations of HCV RNA quantitative kits: a comparative study of 556 cases of hepatitis C[J]. Journal of Clinical Hepatology, 2014, 30(12): 1315-1318. doi: 10.3969/j.issn.1001-5256.2014.12.020 |
[10] | Sun LiMei, Zhao YanMing, Wang YiPeng, Zhao DanTong, Zhang HaiPing, Li ZhuoMin, Wang Yi, Ma YinXue, Yan HuiPing, Liu YanMin. Analysis of clinical significance of combined antigen screening reagents for autoimmune liver disease[J]. Journal of Clinical Hepatology, 2014, 30(5): 405-408. doi: 10.3969/j.issn.1001-5256.2014.05.005 |
[11] | Cao Xiao, Cao QingBao, Zhang GuoQiang, Chang ZaiJuan, Li ShuPing, Xu WeiWei. Analysis of occult hepatitis B virus infection among blood donors in Tangshan, China[J]. Journal of Clinical Hepatology, 2013, 29(2): 117-119. |
[12] | Chen HuiJuan, Zhao ShouSong. Recent insights into the roles of regulatory T cells in viral hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(11): 868-871. |
[13] | Li JinMing. Advice on the detection of antibody and RNA in the guideline for HCV infection[J]. Journal of Clinical Hepatology, 2011, 27(8): 865-867. |
[15] | Wang JingQuan, Cui ShiChang, Yan HuiPing, Dong ShengShan, Li DongCeng, Zhu RenPing. The clinical observation of autoantibody in autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2004, 20(1): 12-13. |
[16] | Zhao Ping, Jiao Jian. Clinical study of HBsAg negative patients with chronic hepatitis B and C super-infection[J]. Journal of Clinical Hepatology, 2004, 20(6): 341-342. |
[17] | Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76. |